To bridge or not to bridge: These are the questions

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 1, 2012, Pages 31-35

  Harrison, Robert W ^a   Ortel, Thomas L ^a   Becker, Richard C ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ANTITHROMBOTIC THERAPY; ARTERIAL THROMBOEMBOLISM; ARTICLE; BLEEDING; BRIDGING ANTICOAGULANT THERAPY; CARDIOVASCULAR PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTIVE SURGERY; EUROPEAN UNION; HEART ATRIUM FIBRILLATION; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; NORTH AMERICA; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK REDUCTION; STROKE; THERAPY; THROMBOEMBOLISM; TREATMENT WITHDRAWAL;

ADMINISTRATION, ORAL; ANTICOAGULANTS; ATRIAL FIBRILLATION; EUROPEAN UNION; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; NORTH AMERICA; PREOPERATIVE CARE; RISK FACTORS; STROKE; THROMBOEMBOLISM;

EID: 84862758160     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0732-8     Document Type: Article

References (22)

1. V Fuster LE Ryden DS Cannom, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the american college of cardiology foundation/American heart association task force on practice guidelines developed in partnership with the European society of cardiology and in collaboration with the European heart rhythm association and the heart rhythm society J Am Coll Cardiol 57 11 e101 e198 21392637 10.1016/j.jacc.2010.09.013
2. BF Gage AD Waterman W Shannon M Boechler MW Rich MJ Radford 2001 Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation J Am Med Assoc 285 22 2864 2870 10.1001/jama.285.22.2864 1:STN:280:DC%2BD3MzntFKgsQ%3D%3D
3. Skolarus LE, Morgenstern LB, Froehlich JB, Lisabeth LD, Brown DL (2011) Guideline-discordant periprocedural interruptions in warfarin therapy. Circ Cardiovasc Qual Outcomes. 4(2):206-210
4. Douketis JD, Spyropoulos AC, Spencer FA et al (2012) Perioperative management of antithrombotic therapy. Antithrombotic therapy and prevention of thrombosis, 9th edn. American college of chest physicians evidence-based clinical practice guidelines. Chest 141(2 suppl):e3265-e3505
5. GM Eisen TH Baron JA Dominitz, et al. 2002 Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures Gastrointest Endosc 55 7 775 779 12024126 10.1016/S0016-5107(02)70402-1
6. JD Douketis MA Crowther SS Cherian 2000 Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey Can J Cardiol 16 3 326 330 10744795 1:STN:280:DC%2BD3c3gvFWhsw%3D%3D
7. DA Garcia S Regan LE Henault, et al. 2008 Risk of thromboembolism with short-term interruption of warfarin therapy Arch Intern Med 168 1 63 69 18195197 10.1001/archinternmed.2007.23 1:CAS:528:DC%2BD1cXhslSntbo%3D
8. DJ Blacker EF Wijdicks RL McClelland 2003 Stroke risk in anticoagulated patients with atrial fibrillation undergoing endoscopy Neurology 61 7 964 968 14557569 10.1212/01.WNL.0000086817.54076.EB
9. S Kaatz JD Douketis H Zhou BF Gage RH White 2010 Risk of stroke after surgery in patients with and without chronic atrial fibrillation J Thromb Haemost 8 5 884 890 20096001 1:STN:280:DC%2BC3crisFSruw%3D%3D
10. JD Douketis PB Berger AS Dunn, et al. 2008 The perioperative management of antithrombotic therapy: American college of chest physicians evidence-based clinical practice guidelines (8th edn) Chest 133 6 Suppl 299S 339S 18574269 10.1378/chest.08-0675 1:CAS:528:DC%2BD1cXptVKhsrw%3D
11. AS Dunn AC Spyropoulos AG Turpie 2007 Bridging therapy in patients on long-term oral anticoagulants who require surgery: the prospective peri-operative enoxaparin cohort trial (PROSPECT) J Thromb Haemost 5 11 2211 2218 17697140 10.1111/j.1538-7836.2007.02729.x 1:CAS:528:DC%2BD2sXhsVSis7fJ
12. Tafur AJ, McBane R, IInd, Wysokinski WE et al (2011) Predictors of major bleeding in peri-procedural anticoagulation management. J Thromb Haemost 10(2):261-267
13. R Pisters DA Lane R Nieuwlaat CB de Vos HJ Crijns GY Lip 2010 A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey Chest 138 5 1093 1100 20299623 10.1378/chest.10-0134
14. BF Gage Y Yan PE Milligan, et al. 2006 Clinical classification schemes for predicting hemorrhage: results from the national registry of atrial fibrillation (NRAF) Am Heart J 151 3 713 719 16504638 10.1016/j.ahj.2005.04.017
15. JD Douketis JA Johnson AG Turpie 2004 Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen Arch Intern Med 164 12 1319 1326 15226166 10.1001/archinte.164.12.1319 1:CAS:528:DC%2BD2cXmtlSnt7Y%3D
16. C Hammerstingl A Schmitz R Fimmers H Omran 2009 Bridging of chronic oral anticoagulation with enoxaparin in patients with atrial fibrillation: results from the prospective BRAVE registry Cardiovasc Ther 27 4 230 238 19903186 10.1111/j.1755-5922.2009.00099.x 1:CAS:528:DC%2BD1MXhs1SjtrfL
17. AK Jaffer M Ahmed DJ Brotman, et al. 2005 Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol J Thromb Thrombolysis 20 1 11 16 16133889 10.1007/s11239-005-3120-9
18. MJ Kovacs C Kearon M Rodger, et al. 2004 Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin Circulation 110 12 1658 1663 15364803 10.1161/01.CIR.0000142859.77578.C9 1:CAS:528:DC%2BD2cXnsVKqurk%3D
19. Malato A, Saccullo G, Lo Coco L et al (2010) Patients requiring interruption of long-term oral anticoagulant therapy: the use of fixed sub-therapeutic doses of low-molecular-weight heparin. J Thromb Haemost 8(1):107-113
20. V Pengo U Cucchini G Denas, et al. 2009 Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study Circulation 119 22 2920 2927 19470892 10.1161/CIRCULATIONAHA.108.823211 1:CAS:528: DC%2BD1MXms1alsLY%3D
21. AC Spyropoulos AG Turpie AS Dunn, et al. 2006 Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry J Thromb Haemost 4 6 1246 1252 16706967 10.1111/j.1538-7836.2006.01908.x 1:CAS:528: DC%2BD28XmsVGhs7g%3D
22. Wysokinski WE, McBane RD, Daniels PR et al (2008) Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc 83(6):639-645